Research Analysts Offer Predictions for RSSS Q1 Earnings

Research Solutions Inc. (NASDAQ:RSSS) – Investment analysts at Maxim Group issued their Q1 2027 earnings estimates for Research Solutions in a research report issued on Thursday, September 10th. Maxim Group analyst A. Klee expects that the company will post earnings per share of $0.02 for the quarter. The consensus estimate for Research Solutions’ current full-year earnings is $0.12 per share. Maxim Group also issued estimates for Research Solutions’ Q2 2027 earnings at $0.02 EPS, Q3 2027 earnings at $0.02 EPS, Q4 2027 earnings at $0.03 EPS, FY2027 earnings at $0.10 EPS, Q1 2028 earnings at $0.02 EPS, Q2 2028 earnings at $0.02 EPS, Q3 2028 earnings at $0.02 EPS, Q4 2028 earnings at $0.03 EPS and FY2028 earnings at $0.11 EPS.

Research Solutions (NASDAQ:RSSS) last issued its quarterly earnings results on Wednesday, September 9th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). The company had revenue of $12.08 million during the quarter, compared to analysts’ expectations of $11.95 million. Research Solutions had a net margin of 5.84% and a return on equity of 16.32%.

Several other research firms also recently weighed in on RSSS. Weiss Ratings restated a “hold (c-)” rating on shares of Research Solutions in a research report on Wednesday, August 12th. Lake Street Capital reduced their price objective on Research Solutions from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Monday, May 18th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $3.83.

Research Solutions Trading Down 7.5%

NASDAQ:RSSS opened at $1.98 on Tuesday. Research Solutions has a 12 month low of $1.96 and a 12 month high of $4.12. The stock has a 50 day moving average of $2.22 and a two-hundred day moving average of $2.30. The firm has a market cap of $66.23 million, a P/E ratio of 22.00 and a beta of 0.75.

Institutional Trading of Research Solutions

A number of hedge funds have recently bought and sold shares of the business. NewEdge Advisors LLC acquired a new position in shares of Research Solutions during the 2nd quarter worth approximately $60,000. Punch & Associates Investment Management Inc. purchased a new stake in shares of Research Solutions in the second quarter valued at approximately $5,922,000. Bard Associates Inc. acquired a new stake in shares of Research Solutions in the second quarter valued at approximately $1,413,000. BlackRock Inc. purchased a new position in Research Solutions during the second quarter worth approximately $332,000. Finally, Dynamic Advisor Solutions LLC lifted its position in Research Solutions by 15.1% during the second quarter. Dynamic Advisor Solutions LLC now owns 365,599 shares of the company’s stock worth $848,000 after buying an additional 47,907 shares in the last quarter. Institutional investors and hedge funds own 33.60% of the company’s stock.

Key Stories Impacting Research Solutions

Here are the key news stories impacting Research Solutions this week:

• Neutral Sentiment: Maxim Group expects Research Solutions to earn approximately $0.02 per share in each quarter of 2027, with fourth-quarter EPS rising to $0.03. The firm projects full-year 2027 EPS of $0.10 and 2028 EPS of $0.11. Research Solutions analyst estimates
• Negative Sentiment: The $0.10 2027 and $0.11 2028 forecasts are below the company’s current full-year consensus estimate of $0.12, suggesting analysts expect relatively modest earnings growth and potentially limiting investor enthusiasm.
• Negative Sentiment: RSSS opened at $1.98, close to its one-year low of $1.96 and below its 50-day and 200-day moving averages of $2.22 and $2.30, respectively. That weak technical positioning may amplify selling pressure when there is no major positive catalyst.

Research Solutions Company Profile

Research Solutions, Inc (NASDAQ:RSSS) is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company’s flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.

Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.